Table of Contents
Volume 7, Issue 11
November 2008
Pages 1705 - 1862
Editor's Corner
-
Cover Caption
News
-
Biochemist Robert Tjian Elected as New Hughes President
Page 1705
Reviews
-
Wnt signaling and senescence: A tug of war in early neoplasia?
Peter D. Adams and Greg H. Enders
Pages 1706 - 1711
-
Androgens and epithelial ovarian cancer: What's the connection?
Beth Y. Karlan and Andrew John Li
Pages 1712 - 1716
Research Paper
-
scFv-Mediated delivery of truncated BID suppresses HER2-positive osteosarcoma growth and metastasis
Le-Qun Shan, Xiu-Chun Qiu, Yan-Ming Xu, Zheng-Gang Ji, Tong-Tao Yang, Xiang Chen, Bao-An Ma, Yong Zhou, Qing-Yu Fan and An-Gang Yang
Pages 1717 - 1722
Commentary
-
Can you tBID on it?
Şahru Yüksel and Nesrin Özören
Pages 1723 - 1725
Research Papers
-
Proteasome-dependent degradation of Chk1 kinase induced by the topoisomerase II inhibitor R16 contributes to its anticancer activity
Jian-Ming Feng, Hong Zhu, Xiao-Wei Zhang, Jian Ding and Ze-Hong Miao
Pages 1726 - 1731
-
Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion
Mariola Kulawiec, Alfiya F. Safina, Mohamed Mokhtar Desouki, Ivan Still, Sei-Ichi Matsui, Andrei Bakin and Keshav K Singh
Pages 1732 - 1743
-
In vitro and in vivo antitumor effect of a trivalent bispecific antibody targeting ErbB2 and CD16
Han Lu, Ming Shi, Mingli Wang, Zhigang Xie, Meiru Hu, Ming Yu, Beifen Shen, Yuanfang Ma and Ning Guo
Pages 1744 - 1750
Commentary
-
Nature’s design – a blueprint for engineered therapeutic antibodies
Ulrich Rodeck and John C. Williams
Pages 1751 - 1752
Research Paper
-
Establishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell line
Alvarez Hector, Jan-Bart M. Koorstra, Seung-Mo Hong, Jurjen J. Boonstra, Winand N.M. Dinjens, Arlene A. Forastiere, Tsung-Teh Wu, Elizabeth Montgomery and James R. Eshleman
Pages 1753 - 1755
Commentary
-
Cellular biometrics in the postgenomics era
Douglas B. Stairs, Shinya Ohashi and Hiroshi Nakagawa
Pages 1756 - 1757
Research Papers
-
c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster
Elaine Y. Chung, Michael Dews, Diana Cozma, Duonan Yu, Erik A. Wentzel, Tsung-Cheng Chang, Janell M. Schelter, Michele A. Cleary, Joshua T. Mendell and Andrei Thomas-Tikhonenko
Pages 1758 - 1764
-
Anti colon cancer components from Lebanese sage (Salvia libanotica) essential oil: Mechanistic basis
Wafica S. Itani, Sarah H. El-Banna, Saadia B. Hassan, Rolf L. Larsson, Ali Bazarbachi and Hala U. Gali-Muhtasib
Pages 1765 - 1773
-
Comedo-Ductal carcinoma in situ: A paradoxical role for programmed cell death
Malathy P.V. Shekhar, Larry Tait, Robert J. Pauley, Gen Sheng Wu, Steven J. Santner, Pratima Nangia-Makker, Varun Shekhar, Hind Nassar, Daniel W. Visscher, Gloria H. Heppner and Fred R. Miller
Pages 1774 - 1782
-
Deficiency of Bloom syndrome helicase activity is radiomimetic
David P. Horowitz, Ozlem Topaloglu, Yonggang Zhang and Fred Bunz
Pages 1783 - 1786
-
Concomitant activation of the JAK/STAT3 and ERK1/2 signaling is involved in leptin-mediated proliferation of renal cell carcinoma Caki-2 cells
Lei Li, Ye Gao, Lin-Lin Zhang and Da-lin He
Pages 1787 - 1792
-
Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification
Open Access Article
Shuaili Chen, Theresa Auletta, Ostap Dovirak, Christina Hutter, Karen Kuntz, Samyra El-ftesi, Jude Kendall, Haiyong Han, Daniel D. Von Hoff, Raheela Ashfaq, Anirban Maitra, Christine A. Iacobuzio-Donahue, Ralph H. Hruban and Robert Lucito
Pages 1793 - 1802
Commentary
-
Amplifying Pak kinases
Bettina Dummler and Jeffrey Field
Pages 1803 - 1805
Research Paper
-
Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma
Tine S. Mantoni, Roy R.E. Schendel, Franz Rödel, Gerald Niedobitek, Osama Al-Assar, Atsuhi Masamune and Thomas B. Brunner
Pages 1806 - 1815
Commentary
-
Tumor: Stroma interactions in pancreatic pancer: Will this sparc prove a raging fire?
Keith A Cengel and Christine Edmonds
Pages 1816 - 1817
Research Papers
-
Co-expression of EGFRvIII with ErbB-2 enhances tumorigenesis: EGFRvIII mediated constitutively activated and sustained signaling pathways, whereas EGF-induced a transient effect on EGFR-mediated signaling pathways
Open Access Article
Hong Yu, Xiaoqi Gong, Xunyi Luo, Wei Han, Ge Hong, Baljit Singh and Careen K. Tang
Pages 1818 - 1828
-
Effect of a novel inhibitory mAb antibody against β-subunit of F1F0 ATPase on HCC
Jingbo Wang, Ying Han, Jie Liang, Xin Cheng, Li Yan, Yingmei Wang, Jingmei Liu, Guanhong Luo, Xiong Cheng, Lina Zhao, Xinmin Zhou, Kaichun Wu and Daiming Fan
Pages 1829 - 1835
Commentary
-
Targeting cell surface F1F0 ATP synthase in cancer therapy
Yvonne M. Mowery and Salvatore V. Pizzo
Pages 1836 - 1838
Research Paper
-
Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach
Yifei Xing, Mei Liu, Yuefeng Du, Feng Qu, Yangsheng Li, Qingwei Zhang, Yajun Xiao, Jun Zhao, Fuqing Zeng and Chuanguo Xiao
Pages 1839 - 1848
Commentary
-
New insights into the role of CXCR4 in prostate cancer metastasis
Candece L. Gladson and Danny R. Welch
Pages 1849 - 1851
Research Paper
-
An investigation of the effects of nanosize delivery system for antisense oligonucleotide on esophageal squamous cancer cells
Huixiang Li, Jin Wang, Tianyang Zhou, Yingge Zhang and Zhenzhong Zhang
Pages 1852 - 1859
Commentary
-
Nanosize delivery as an emerging platform for cancer therapy
Chun-Qi Li and Guang-Xian Zhang
Pages 1860 - 1862